TITLE

Enhancement of Transdermal Penetration and Bioavailability of Poorly Soluble Acyclovir Using Solid Lipid Nanoparticles Incorporated in Gel Cream

AUTHOR(S)
GIDE, P. S.; GIDWANI, S. K.; KOTHULE, K. U.
PUB. DATE
March 2013
SOURCE
Indian Journal of Pharmaceutical Sciences;Mar/Apr2013, Vol. 75 Issue 2, p138
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The objective of this work was to increase the amount of acyclovir in the basal epidermis, site of herpes virus simplex infection, using the solid lipid nanoparticles loaded gel cream as carriers. Solid lipid nanoparticles were prepared by high pressure homogenisation method and incorporated in a semisolid submicron gel cream. Acyclovir distribution into rat skin after topical application of solid lipid nanoparticles loaded gel cream was determined by fabricated Franz diffusion cell. The results showed that, the quantity of the acyclovir in the basal epidermis with the solid lipid nanoparticles loaded submicron gel cream was two folds times more than marketed acyclovir gel cream. This type of carrier can improve acyclovir loaded therapy since it increases drug retention in the basal epidermis.
ACCESSION #
89747064

 

Related Articles

  • A Temporal Analysis of Acyclovir Inhibition of Induced Herpes Simplex Virus Type 1 In Vivo... Sawtell, N.M.; Bernstein, David I.; Stanberry, Lawrence R. // Journal of Infectious Diseases;9/1/99, Vol. 180 Issue 3, p821 

    Presents a temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 in vivo reactivation in the mouse trigeminal ganglia. Factor that influence the efficacy of acyclovir; Resulting reduction in reactivation following the administration of the antiviral compound.

  • Biochemical Characterization of a Virus Isolate, Recovered from a Patient with Herpes Keratitis, That Was Clinically Resistant to Acyclovir. Sarisky, Robert T.; Cano, Rachel; Nguyen, Tammy T.; Wittrock, Robert J.; Duffy, Karen E.; Clark, Phil; Bartus, Joan O.; Bacon, Teresa H.; Caspers-Velu, Laure; Hodinka, Richard L.; Leary, Jeffry J. // Clinical Infectious Diseases;12/15/2001, Vol. 33 Issue 12, p2034 

    In vitro susceptibility assays of herpes simplex virus (HSV) do not necessarily correlate with treatment outcome. An HSV type 1 (HSV-1) isolate, N4, recovered from a patient who presented with herpes keratitis with localized immunosuppression, was characterized for susceptibility. Although the...

  • Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection. Hasler-Nguyen, Nathalie; Shelton, Donald; Ponard, Gilbert; Bader, Marlene; Schaffrik, Martina; Mallefet, Pascal // BMC Dermatology;2009, Vol. 9, Special section p1 

    Background: Herpes simplex virus infection (HSV) is a common and ubiquitous infection of the skin which causes mucocutaneous lesions called cold sores (herpes labialis) or fever blisters. It is estimated that approximately 80% of the population worldwide are carriers of the Herpes simplex virus,...

  • Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug. Sharma1, Anshu; Jain, C.P. // International Journal of Drug Delivery;2011, Vol. 3 Issue 4, p149 

    Poorly water soluble compounds have solubility and dissolution related bioavailability problems. The present review deals in detail about solid dispersion technology and its manufacturing techniques at laboratory and industrial level. This highlight about various hydrophilic polymers used in...

  • Herpes Simplex Virus Resistant to Acyclovir. Englund, Janet A.; Zimmerman, Mark E.; Swierkosz, Ella M.; Goodman, Jesse L.; Scholl, David R.; Balfour Jr., Henry H. // Annals of Internal Medicine;3/15/90, Vol. 112 Issue 6, p416 

    Presents a study which aims to determine the sensitivity of herpes simplex virus isolates to acyclovir and the importance of resistant isolates in hospitalized patients. Description of clinical viral procedures considered in the study; Clinical characteristics of patients with herpes simplex...

  • Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population. Darville, J M; Ley, B E; Roome, A P C H; Foot, A B M // Bone Marrow Transplantation;9/15/98, Vol. 22 Issue 6, p587 

    Over a 3-month period, four patients who had received unrelated donor (UD) bone marrow transplants (BMT) presented with severe mucocutaneous herpes simplex virus (HSV) infection while receiving acyclovir (ACV) prophylaxis. Sensitivity testing of the isolates revealed three to be...

  • Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation. Wade, James C.; Newton, Barbara; Flournoy, Nancy; Meyers, Joel D. // Annals of Internal Medicine;Jun84, Vol. 100 Issue 6, p823 

    Deals with a study of the effectiveness of oral acyclovir in the prevention of herpes simplex virus reactivation after marrow transplantation in a double-blind, placebo-controlled trial. Methodology used in the study; Results and discussion.

  • Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania. Tanton, Clare; Weiss, Helen A; LeGoff, Jerome; Changalucha, John; Clayton, Tim C; Ross, David A; Belec, Laurent; Hayes, Richard J; Watson-Jones, Deborah // Sexually Transmitted Infections;Aug2011, Vol. 87 Issue 5, p406 

    Objectives: Few studies have examined the frequency and duration of genital herpes simplex virus (HSV) shedding in sub-Saharan Africa. This study describes HSV shedding patterns among a sample of HSV-2-seropositive women enrolled in a placebo-controlled trial of HSV suppressive...

  • Oral acyclovir lowered risk for developmental delays in infants with HSV. Southall, Jennifer; Volansky, Rob // Infectious Diseases in Children;Nov2010, Vol. 23 Issue 11, p27 

    The article focuses on the study which revealed that infants with herpes simplex virus who underwent suppressive oral acyclovir therapy for 6 months were less likely to suffer from neurodevelopmental outcomes and obtained fewer skin lesion recurrences when compared with those assigned placebo,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics